The US Food and Drug Administration (FDA) has convened a panel to discuss the use of a common antidepressant during pregnancy.

Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression and other mental health conditions.

Experts are concerned the panel has cast undue doubt on the medication, and changes shouldn’t be made without evidence.

Guest/s

• Dr Carolyn Breadon, perinatal psychiatrist at Alfred Health

References

• Paternal Depression as a Risk Factor for Neurodevelopmental Disorders in Offspring: Implications for Maternal Depression and Its Treatment During Pregnancy
• Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children